Identification of new small molecule allosteric SHP2 inhibitor through pharmacophore-based virtual screening, molecular docking, molecular dynamics simulation studies, synthesis and in vitro evaluation

References

• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
   Google Scholar
• Asmamaw, M. D., Shi, X.-J., Zhang, L.-R., & Liu, H.-M. (2022). A comprehensive review of SHP2 and its role in cancer. Cellular Oncology (Dordrecht), 45(5), 729–753. https://doi.org/10.1007/s13402-022-00698-1
   PubMed Web of Science ®Google Scholar
• Baell, J. B., & Holloway, G. A. (2010). New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. Journal of Medicinal Chemistry, 53(7), 2719–2740. https://doi.org/10.1021/jm901137j
   PubMed Web of Science ®Google Scholar
• Berman, H., Henrick, K., & Nakamura, H. (2003). Announcing the worldwide Protein Data Bank. Nature Structural Biology, 10(12), 980–980. https://doi.org/10.1038/nsb1203-980
   PubMedGoogle Scholar
• Biovia, D. S. (2021). Discovery studio visualizer. Dassault Systemes.
   Google Scholar
• Bramucci, E., et al. (2012). PyMod: Sequence similarity searches, multiple sequence-structure alignments, and homology modeling within PyMOL. Italian Society of Bioinformatics (BITS), 13(4), 1–6. https://doi.org/10.1186/1471-2105-13-s4-s2
   Google Scholar
• CCG, Inc. (2016). Molecular operating environment (MOE), Chemical Computing Group Inc 1010 Sherbooke St. West, Suite# 910, Montreal QC, Canada, 2016.
   Google Scholar
• Chan, G., Kalaitzidis, D., & Neel, B. G. (2008). The tyrosine phosphatase Shp2 (PTPN11) in cancer. Cancer Metastasis Reviews, 27(2), 179–192. https://doi.org/10.1007/s10555-008-9126-y
   PubMed Web of Science ®Google Scholar
• Chen, Y.-N P., LaMarche, M. J., Chan, H. M., Fekkes, P., Garcia-Fortanet, J., Acker, M. G., Antonakos, B., Chen, C. H.-T., Chen, Z., Cooke, V. G., Dobson, J. R., Deng, Z., Fei, F., Firestone, B., Fodor, M., Fridrich, C., Gao, H., Grunenfelder, D., Hao, H.-X., … Fortin, P. D. (2016). Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases. Nature, 535(7610), 148–152. https://doi.org/10.1038/nature18621
   PubMed Web of Science ®Google Scholar
• Cheng, F., Li, W., Zhou, Y., Shen, J., Wu, Z., Liu, G., Lee, P. W., & Tang, Y. (2012). admetSAR: A comprehensive source and free tool for assessment of chemical ADMET properties. Journal of Chemical Information and Modeling, 52(11), 3099–3105. https://doi.org/10.1021/ci300367a
   PubMed Web of Science ®Google Scholar
• Eisenhaber, F., Lijnzaad, P., Argos, P., Sander, C., & Scharf, M. (1995). The double cubic lattice method: Efficient approaches to numerical integration of surface area and volume and to dot surface contouring of molecular assemblies. Journal of Computational Chemistry, 16(3), 273–284. https://doi.org/10.1002/jcc.540160303
   Web of Science ®Google Scholar
• Galluzzi, L., Kepp, O., Vander Heiden, M. G., & Kroemer, G. (2013). Metabolic targets for cancer therapy. Nature Reviews Drug Discovery, 12(11), 829–846. https://doi.org/10.1038/nrd4145
   PubMed Web of Science ®Google Scholar
• Garcia Fortanet, J., Chen, C. H.-T., Chen, Y.-N P., Chen, Z., Deng, Z., Firestone, B., Fekkes, P., Fodor, M., Fortin, P. D., Fridrich, C., Grunenfelder, D., Ho, S., Kang, Z. B., Karki, R., Kato, M., Keen, N., LaBonte, L. R., Larrow, J., Lenoir, F., … LaMarche, M. J. (2016). Allosteric inhibition of SHP2: Identification of a potent, selective, and orally efficacious phosphatase inhibitor. Journal of Medicinal Chemistry, 59(17), 7773–7782. https://doi.org/10.1021/acs.jmedchem.6b00680
   PubMed Web of Science ®Google Scholar
• Gee, K. R., Sun, W. C., Bhalgat, M. K., Upson, R. H., Klaubert, D. H., Latham, K. A., & Haugland, R. P. (1999). Fluorogenic substrates based on fluorinated umbelliferones for continuous assays of phosphatases and beta-galactosidases. Analytical Biochemistry, 273(1), 41–48. https://doi.org/10.1006/abio.1999.4202
   PubMed Web of Science ®Google Scholar
• Ghemrawi, R., Khair, M., Hasan, S., Aldulaymi, R., AlNeyadi, S. S., Atatreh, N., & Ghattas, M. A. (2022). The discovery of potent SHP2 inhibitors with anti-proliferative activity in breast cancer cell lines. International Journal of Molecular Sciences, 23(8), 4468. https://doi.org/10.3390/ijms23084468
   PubMed Web of Science ®Google Scholar
• Giordano, D., Biancaniello, C., Argenio, M. A., & Facchiano, A. (2022). Drug design by pharmacophore and virtual screening approach. Pharmaceuticals (Basel, Switzerland), 15(5), 646. https://doi.org/10.3390/ph15050646
   PubMedGoogle Scholar
• Grygorenko, O. O. (2021). The science and business of organic chemistry and beyond. European Journal of Organic Chemistry, 2021(47), 6474–6477. https://doi.org/10.1002/ejoc.202101210
   Web of Science ®Google Scholar
• Jin, W.-Y., Ma, Y., Li, W.-Y., Li, H.-L., & Wang, R.-L. (2018). Scaffold-based novel SHP2 allosteric inhibitors design using Receptor-Ligand pharmacophore model, virtual screening and molecular dynamics. Computational Biology and Chemistry, 73, 179–188. https://doi.org/10.1016/j.compbiolchem.2018.02.004
   PubMed Web of Science ®Google Scholar
• Kawata, M., & Nagashima, U. (2001). Particle mesh Ewald method for three-dimensional systems with two-dimensional periodicity. Chemical Physics Letters, 340(1-2), 165–172. https://doi.org/10.1016/S0009-2614(01)00393-1
   Web of Science ®Google Scholar
• Kong, J., & Long, Y.-Q. (2022). Recent advances in the discovery of protein tyrosine phosphatase SHP2 inhibitors. RSC Medicinal Chemistry, 13(3), 246–257. https://doi.org/10.1039/D1MD00386K
   PubMedGoogle Scholar
• Kumar, S., & Ayyannan, S. R. (2023). Identification of new small molecule monoamine oxidase-B inhibitors through pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation studies. Journal of Biomolecular Structure & Dynamics, 41(14), 6789–6810. https://doi.org/10.1080/07391102.2022.2112082
   PubMed Web of Science ®Google Scholar
• Kumar, S., Jaiswal, S., Gupta, S. K., & Ayyannan, S. R. (2023). Benzimidazole-derived carbohydrazones as dual monoamine oxidases and acetylcholinesterase inhibitors: Design, synthesis, and evaluation. Journal of Biomolecular Structure & Dynamics, 1–20. https://doi.org/10.1080/07391102.2023.2224887
   Web of Science ®Google Scholar
• Laskowski, R. A., Rullmannn, J. A., MacArthur, M. W., Kaptein, R., & Thornton, J. M. (1996). AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR. Journal of Biomolecular NMR, 8(4), 477–486. https://doi.org/10.1007/bf00228148
   PubMed Web of Science ®Google Scholar
• Lipinski, C. (2004). Lead-and drug-like compounds: The rule-of-five revolution. Drug Discovery Today: Technologies, 1(4), 337–341. https://doi.org/10.1016/j.ddtec.2004.11.007
   PubMedGoogle Scholar
• Liu, W.-S., Jin, W.-Y., Zhou, L., Lu, X.-H., Li, W.-Y., Ma, Y., & Wang, R.-L. (2019). Structure based design of selective SHP2 inhibitors by De novo design, synthesis and biological evaluation. Journal of Computer-Aided Molecular Design, 33(8), 759–774. https://doi.org/10.1007/s10822-019-00213-z
   PubMed Web of Science ®Google Scholar
• Malde, A. K., Zuo, L., Breeze, M., Stroet, M., Poger, D., Nair, P. C., Oostenbrink, C., & Mark, A. E. (2011). An automated force field topology builder (ATB) and repository: Version 1.0. Journal of Chemical Theory and Computation, 7(12), 4026–4037. https://doi.org/10.1021/ct200196m
   PubMed Web of Science ®Google Scholar
• Mitra, R., & Ayyannan, S. R. (2021). Small-molecule inhibitors of Shp2 phosphatase as potential chemotherapeutic agents for glioblastoma: A minireview. ChemMedChem. 16(5), 777–787. https://doi.org/10.1002/cmdc.202000706
   PubMed Web of Science ®Google Scholar
• National Library of Medicine. (2023). Clinical trials: Studies found for: Shp2 | Recruiting, Not yet recruiting, active, not recruiting, completed studies. https://clinicaltrials.gov/search?term=shp2
   Google Scholar
• Neel, B. G., Gu, H., & Pao, L. (2003). The ‘Shp’ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends in Biochemical Sciences, 28(6), 284–293. https://doi.org/10.1016/S0968-0004(03)00091-4
   PubMed Web of Science ®Google Scholar
• Nunes-Xavier, C. E., Mingo, J., López, J. I., & Pulido, R. (2019). The role of protein tyrosine phosphatases in prostate cancer biology. Biochimica et Biophysica Acta. Molecular Cell Research, 1866(1), 102–113. https://doi.org/10.1016/j.bbamcr.2018.06.016
   PubMed Web of Science ®Google Scholar
• Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera—a visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/10.1002/jcc.20084
   PubMed Web of Science ®Google Scholar
• Qu, C. K. (2000). The SHP-2 tyrosine phosphatase: Signaling mechanisms and biological functions. Cell Research, 10(4), 279–288. https://doi.org/10.1038/sj.cr.7290055
   PubMed Web of Science ®Google Scholar
• Richards, C. E., Elamin, Y. Y., Carr, A., Gately, K., Rafee, S., Cremona, M., Hanrahan, E., Smyth, R., Ryan, D., Morgan, R. K., Kennedy, S., Hudson, L., Fay, J., O'Byrne, K., Hennessy, B. T., & Toomey, S. (2023). Protein tyrosine phosphatase non-receptor 11 (PTPN11/Shp2) as a driver oncogene and a novel therapeutic target in non-small cell lung cancer (NSCLC). International Journal of Molecular Sciences, 24(13), 10545. https://doi.org/10.3390/ijms241310545
   PubMed Web of Science ®Google Scholar
• Saez-Ayala, M., Hoffer, L., Abel, S., Ben Yaala, K., Sicard, B., Andrieu, G. P., Latiri, M., Davison, E. K., Ciufolini, M. A., Brémond, P., Rebuffet, E., Roche, P., Derviaux, C., Voisset, E., Montersino, C., Castellano, R., Collette, Y., Asnafi, V., Betzi, S., … Morelli, X. (2023). From a drug repositioning to a structure-based drug design approach to tackle acute lymphoblastic leukemia. Nature Communications, 14(1), 3079. https://doi.org/10.1038/s41467-023-38668-2
   PubMed Web of Science ®Google Scholar
• Savitzky, A., & Golay, M. J. E. (1964). Smoothing and differentiation of data by simplified least squares procedures. Analytical Chemistry, 36(8), 1627–1639. https://doi.org/10.1021/ac60214a047
   Web of Science ®Google Scholar
• Sever, R., & Brugge, J. S. (2015). Signal transduction in cancer. Cold Spring Harbor Perspectives in Medicine, 5(4), a006098–a006098. https://doi.org/10.1101/cshperspect.a006098
   PubMed Web of Science ®Google Scholar
• Song, Y., Zhao, M., Zhang, H., & Yu, B. (2022). Double-edged roles of protein tyrosine phosphatase SHP2 in cancer and its inhibitors in clinical trials. Pharmacology & Therapeutics, 230, 107966. https://doi.org/10.1016/j.pharmthera.2021.107966
   PubMed Web of Science ®Google Scholar
• Sunseri, J., & Koes, D. R. (2016). Pharmit: Interactive exploration of chemical space. Nucleic Acids Research, 44(W1), W442–W448. https://doi.org/10.1093/nar/gkw287
   PubMed Web of Science ®Google Scholar
• Takeuchi, T., Nomura, Y., Tamita, T., Nishikawa, R., Kakinuma, H., Kojima, N., Hitaka, K., Tamura, Y., Kamitani, M., Mima, M., Nozoe, A., & Hayashi, M. (2023). Discovery of TP0597850: A selective, chemically stable, and slow tight-binding matrix metalloproteinase-2 inhibitor with a phenylbenzamide–pentapeptide hybrid scaffold. Journal of Medicinal Chemistry, 66(1), 822–836. https://doi.org/10.1021/acs.jmedchem.2c01698
   PubMed Web of Science ®Google Scholar
• Thomas, D., Karle, C. A., & Kiehn, J. (2006). The cardiac hERG/IKr potassium channel as pharmacological target: Structure, function, regulation, and clinical applications. Current Pharmaceutical Design, 12(18), 2271–2283. https://doi.org/10.2174/138161206777585102
   PubMed Web of Science ®Google Scholar
• Tripathi, R. K. P., & Ayyannan, S. R. (2021). Emerging chemical scaffolds with potential SHP2 phosphatase inhibitory capabilities – A comprehensive review. Chemical Biology & Drug Design, 97(3), 721–773. https://doi.org/10.1111/cbdd.13807
   PubMed Web of Science ®Google Scholar
• Tyagi, R., et al. (2022). Chapter 17 - pharmacophore modeling and its applications, in bioinformatics (D. B. Singh and R. K. Pathak, Eds., pp. 269–289). Academic Press.
   Google Scholar
• Wang, X., Wang, R., Zhang, Z.-S., Zhang, G.-Y., Jin, Z., Shen, R., Du, D., & Tang, Y.-Z. (2022). Semisynthetic pleuromutilin antimicrobials with therapeutic potential against methicillin-resistant Staphylococcus aureus by targeting 50S ribosomal subunit. European Journal of Medicinal Chemistry, 237, 114341. https://doi.org/10.1016/j.ejmech.2022.114341
   PubMed Web of Science ®Google Scholar
• Wu, J., Li, W., Zheng, Z., Lu, X., Zhang, H., Ma, Y., & Wang, R. (2021). Design, synthesis, biological evaluation, common feature pharmacophore model and molecular dynamics simulation studies of ethyl 4-(phenoxymethyl)-2-phenylthiazole-5-carboxylate as Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitors. Journal of Biomolecular Structure & Dynamics, 39(4), 1174–1188. https://doi.org/10.1080/07391102.2020.1726817
   PubMed Web of Science ®Google Scholar
• Xiang, H., Liu, R., Zhang, X., An, R., Zhou, M., Tan, C., Li, Q., Su, M., Guo, C., Zhou, L., Li, Y., & Wang, R. (2023). Discovery of small-molecule autophagy inhibitors by disrupting the protein–protein interactions involving autophagy-related 5. Journal of Medicinal Chemistry, 66(4), 2457–2476. https://doi.org/10.1021/acs.jmedchem.2c01233
   PubMed Web of Science ®Google Scholar
• Yu, Z.-H., Chen, L., Wu, L., Liu, S., Wang, L., & Zhang, Z.-Y. (2011). Small molecule inhibitors of SHP2 tyrosine phosphatase discovered by virtual screening. Bioorganic & Medicinal Chemistry Letters, 21(14), 4238–4242. https://doi.org/10.1016/j.bmcl.2011.05.078
   PubMed Web of Science ®Google Scholar
• Yuan, X., Bu, H., Zhou, J., Yang, C.-Y., & Zhang, H. (2020). Recent advances of SHP2 inhibitors in cancer therapy: Current development and clinical application. Journal of Medicinal Chemistry, 63(20), 11368–11396. https://doi.org/10.1021/acs.jmedchem.0c00249
   PubMed Web of Science ®Google Scholar
• Zeiger, E. (2019). The test that changed the world: The Ames test and the regulation of chemicals. Mutation Research. Genetic Toxicology and Environmental Mutagenesis, 841, 43–48. https://doi.org/10.1016/j.mrgentox.2019.05.007
   PubMed Web of Science ®Google Scholar
• Zhou, R. (2003). Free energy landscape of protein folding in water: Explicit vs. implicit solvent. Proteins: Structure, Function, and Bioinformatics, 53(2), 148–161. https://doi.org/10.1002/prot.10483
   PubMed Web of Science ®Google Scholar